Topic: drug manufacturing
Higher operating costs were behind a 17% slide in pretax profits last year at Allergan’s Mayo, Ireland, facility that produces Botox.
Advent, which bought Sanofi's Eastern European generics unit Zentiva for $2.2 billion last year, has now bought a Romanian drug maker from Alvogen.
With global recalls of tainted drugs growing more frequent, the consolidation of drug manufacturing abroad is raising eyebrows from U.S. regulators.
The way CEO Kåre Schultz figures it, Teva Pharmaceutical can make more manufacturing cuts after reaching its $3 billion cost reduction goal.
A manufacturing defect led to a 'softening' in response rates with a combo of its NKTR-214 and Opdivo in clinical trials, Nektar said.
With its oral semaglutide up for FDA review, Novo Nordisk is hunting for opportunities to boost its supply chain, and it found one in North Carolina.
With Yescarta on the market and other CAR-Ts on their way, Gilead’s Kite Pharma planted the flag for another manufacturing site.
Wednesday, May 2, 2018
The pharmaceutical industry has experienced a trend in the number of accelerated approval designations for drugs (e.g. orphan drugs, breakthrough therapies, accelerated approvals, and FDA priority reviews) being developed.
Novo Nordisk is investing nearly $100 million in its massive site in Denmark to make next-generation insulins and other drugs.
CDMOs Cambrex and Ajinomoto Bio-Pharma Services upgraded manufacturing plants, Takeda scored an albumin approval via its Shire deal, and more.